Aveanna Healthcare (AVAH) Fundamental Analysis: Revenue, Earnings & Valuation

6.62 / 10

Outperform

Fundamentals are rated Outperform with a 6.6/10 score. Strong PB‑ROE, Revenue‑MV and earnings growth drive optimism, while cash‑related metrics lag, creating mixed signals yet an overall bullish outlook.

Analysis Checks(8/10)

Revenue-MV

Value1.01

Score2/3

Weight8.85%

1M Return3.24%

Net cash flow from operating activities per share (YoY growth rate %)

Value-29.92

Score2/3

Weight5.59%

1M Return2.28%

PB-ROE

Value-0.10

Score3/3

Weight23.94%

1M Return8.31%

Basic earnings per share (YoY growth rate %)

Value1950.00

Score3/3

Weight12.97%

1M Return4.72%

Total profit (YoY growth rate %)

Value2008.60

Score3/3

Weight13.96%

1M Return5.14%

Net cash flow from operating activities (YoY growth rate %)

Value285.63

Score2/3

Weight3.97%

1M Return1.55%

Cash-UP

Value-0.69

Score1/3

Weight1.62%

1M Return0.66%

Diluted earnings per share (YoY growth rate %)

Value1850.00

Score3/3

Weight13.77%

1M Return5.00%

Asset-MV

Value-0.49

Score2/3

Weight18.68%

1M Return5.83%

Cash-MV

Value-0.47

Score0/3

Weight-3.35%

1M Return-1.72%

Is AVAH fundamentally strong?

AVAH scores 6.62/10 on fundamentals and holds a Discounted valuation at present. Backed by its 0.00% ROE, 9.25% net margin, 6.08 P/E ratio, 7.01 P/B ratio, and 208.57% earnings growth, these metrics solidify its Outperform investment rating.